| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.0062 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0017 | 1 |